Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB00041"

PredicateValue (sorted: none)
rdf:type
owl:sameAs
owl:sameAs
drugbank:interactsWith
drugbank:drugCategory
drugbank:interactsWith
rdfs:label
"Aldesleukin"
owl:sameAs
drugbank:interactsWith
owl:sameAs
drugbank:drugCategory
owl:sameAs
drugbank:description
"Aldesleukin, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an analog of the human interleukin-2 gene. Genetic engineering techniques were used to modify the human IL-2 gene, and the resulting expression clone encodes a modified human interleukin-2. This recombinant form differs from native interleukin-2 in the following ways: a) Aldesleukin is not glycosylated because it is derived from E. coli; b) the molecule has no N-terminal alanine; the codon for this amino acid was deleted during the genetic engineering procedure; c) the molecule has serine substituted for cysteine at amino acid position 125."

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines3/drugbank_small.nt

The resource appears as object in 6 triples

Context graph